Enhanced cell permeability of kojic acid-phenylalanine amide with metal complex

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 2, 2010, Pages 738-741

  Kwak, Seon Yeong ^a   Noh, Jin Mi ^a   Park, So Hee ^b   Byun, Jang Woong ^a   Choi, Hye Ryung ^b   Park, Kyoung Chan ^b   Lee, Yoon Sik ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Cell permeability; Kojic acid derivatives; Melanogenesis inhibition; Metal complex; Tyrosinase inhibitor

Indexed keywords

KOJIC ACID; MELANIN; METAL COMPLEX; PHENYLALANINE;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; DRUG ACTIVITY; DRUG INHIBITION; DRUG STRUCTURE; INFRARED SPECTROSCOPY; LIPOPHILICITY; MELANOCYTE; MELANOGENESIS;

ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; COORDINATION COMPLEXES; MELANINS; MICE; MONOPHENOL MONOOXYGENASE; PHENYLALANINE; PYRONES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

BASIDIOMYCOTA;

EID: 72249091474     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.11.069     Document Type: Article

References (28)

1. Zelphati O., and Szoka Jr. F.C. Pharm. Res. 13 (1996) 1367
2. Zelphati O., and Szoka Jr. F.C. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11493
3. Conradi R.A., Hilgers A.R., Ho N.F.H., and Burton P.S. Pharm. Res. 8 (1991) 1453
4. Conradi R.A., Hilgers A.R., Ho N.F.H., and Burton P.S. Pharm. Res. 9 (1992) 435
5. Pooga M., Kut C., Kihlmark M., Hallbrink M., Fernaeus S., Raid R., Land T., Hallberg E., Bartfai T., and Langel U. FASEB J. 15 (2001) 1451
6. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., and Barsoum J. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 664
7. Wyman T.B., Nicol F., Zelphati O., Scaria P.V., Plank C., and Szoka Jr. F.C. Biochemistry 36 (1997) 3008
8. Fernandez-Carneado J., Kogan M.J., Castel S., and Giralt E. Angew. Chem., Int. Ed. 43 (2004) 1811
9. Morris M.C., Depollier J., Mery J., Heitz F., and Divita G. Nat. Biotechnol. 19 (2001) 1173
10. Sheldon K., Liu D., Ferguson J., and Gariepy J. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 2056
11. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., and Rothbard J.B. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 13003
12. Kahn V., Ben-Shalom N., and Zakin V. J. Agric. Food. Chem. 45 (1997) 4460
13. Burdock G.A., Soni M.G., and Carabin I.G. Regul. Toxicol. Pharmacol. 33 (2001) 80
14. Noh J.M., Kwak S.Y., Kim D.H., and Lee Y.S. Biopolymers 88 (2007) 300
15. Noh J.M., Kwak S.Y., Seo H.S., Kim B.G., and Lee Y.S. Bioorg. Med. Chem. Lett. 19 (2009) 5586
16. Albert A., and Glendhill W.S. Biochem. J. 41 (1947) 529
17. 2-O).
18. 2 (3) in the filtrate was concentrated under low pressure, and precipitated with cold diethyl either. The white powder was further washed with diethyl ether and dried in vacuo.
19. Barret M.C., Mahon M.F., Molloy K.C., Steed J.W., and Wright P. Inorg. Chem. 40 (2001) 4384
20. Emami S., Hosseinimehr S.J., Taghdisi S.M., and Akhlaghpoor S. Bioorg. Med. Chem. Lett. 17 (2007) 45
21. 2 (3) by dropwise. Then, its pH was adjusted to 6.0-7.0 with aq NaOH solution (0.25 N). The metal complexes (4, 5) were completely formed at rt within 3 h. The final products were collected by filtration and washed intensively with distilled water to remove salts.
22. Dwyer F.P. In: Dwyer F.P., and Mellor D.P. (Eds). Chelating Agents and Metal Chelates (1964), Academic Press, New York 335-371
23. Dawson R.M., Elliot D.C., Elliot W.H., and Jones K.M. Data for Biochemical Research (1989), Clarendon Press Oxford, Oxford pp 399-416
24. Mushroom tyrosinase inhibition assay: Seventy microliters of phosphate buffer (pH 6.8, 0.1 M) containing inhibitor dissolved in DMSO (10 μl) were mixed with 10 μl of 100 μg/ml mushroom tyrosinase, and then 10 μl of 10 mM l-DOPA were added. Following incubation at 37 °C, absorbance was measured every 10 min for at least 1 h at 475 nm. The % inhibitory activity was calculated by the following formula; (A - B)/A × 100 (A: absorbance of reference solution; B: absorbance of test sample solution). Each experiment was performed in triplicate and averaged.
25. Ohyama Y., and Mishima Y. Frag. J. 6 (1990) 53
26. Crystal violet assay: cell viability was determined using a crystal violet assay (Dooley et al. 1994), After incubation with the samples for 24 h, culture media were removed and replaced with 0.1% crystal violet in 10% ethanol. Mel-Ab cells were then stained for 5 min at room temperature and rinsed four times. The crystal violet retained by adherent cells was then extracted with 95% ethanol, and absorbance was determined at 590 nm using an ELISA reader (TECAN, Salzburg, Austria). Each experiment was performed in triplicate and averaged.
27. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Adv. Drug Delivery Rev. 23 (1997) 3
28. 2. Effects of the inhibitors on melanin formation in Mel-Ab cell line were estimated. When the samples were treated at the concentrations of 10 μM and 100 μM for four days, the inhibitors-treated cells produced much less amount of melanin than the cells without inhibitors. The melanin contents of Mel-Ab cells were measured spectrophotometrically in the experimental period. Each experiment was performed in triplicate and averaged.